Viona Pharmaceuticals Inc. is recalling 6,048 pumps of Dapsone Gel 7.5% (dapsone), a prescription topical medication used to treat acne. The recall was issued because the medication has started to crystallize inside the pump container. This defect can prevent the gel from being dispensed correctly or affect the texture and consistency of the treatment.
Crystallization within the gel can cause the pump mechanism to clog or lead to a gritty texture that may irritate the skin. This issue can also result in an inconsistent or incorrect dose of the medication being applied.
You have 2 options:
Rx Only. Manufactured by Zydus Lifesciences Ltd., India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.